» Articles » PMID: 28040359

TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential

Overview
Journal Eur Urol
Specialty Urology
Date 2017 Jan 2
PMID 28040359
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review).

Karaviti E, Kontogiannis A, Anastopoulos A, Kotteas E, Gomatou G Mol Clin Oncol. 2023; 19(2):61.

PMID: 37424625 PMC: 10326563. DOI: 10.3892/mco.2023.2657.


Role of telomere length in human carcinogenesis (Review).

Tsatsakis A, Oikonomopoulou T, Nikolouzakis T, Vakonaki E, Tzatzarakis M, Flamourakis M Int J Oncol. 2023; 63(1).

PMID: 37232367 PMC: 10552730. DOI: 10.3892/ijo.2023.5526.


promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance.

Liu T, Li S, Xia C, Xu D Front Immunol. 2023; 13:1071390.

PMID: 36713366 PMC: 9877314. DOI: 10.3389/fimmu.2022.1071390.


Detection of Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances.

Hasanau T, Pisarev E, Kisil O, Nonoguchi N, Le Calvez-Kelm F, Zvereva M Biomedicines. 2022; 10(3).

PMID: 35327529 PMC: 8945783. DOI: 10.3390/biomedicines10030728.


Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract.

Taylor A, Newell B, Chinnaiyan A, Hafez K, Weizer A, Spratt D Eur Urol Open Sci. 2022; 35:74-78.

PMID: 35024637 PMC: 8738896. DOI: 10.1016/j.euros.2021.11.007.